Abstract
With the introduction of new anatomical and functional imaging modalities, mainly positron emission tomographycomputed tomography (PET-CT) and multi-parametric magnetic resonance imaging, the eventual origin of biochemical recurrence after curative treatment for prostate cancer can be detected at its earliest stage. Targeted treatment strategies to this local or oligometastatic relapse will be successful in postponing the initiation of systemic treatment, thereby delaying the occurrence of the castrate resistant state and, eventually, improve survival.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
